AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(5), 2001, pp. 414-419
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Troyer, J.
Right arrow Articles by Murphy, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Troyer, J.
Right arrow Articles by Murphy, B.
Related Collections
Right arrow Vector Biology
Right arrow Dengue
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 5, 414-419
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes

JM Troyer, KA Hanley, SS Whitehead, D Strickman, RA Karron, AP Durbin, and BR Murphy

2Adelta30 is a live dengue-4 virus vaccine candidate with a 30-nucleotide deletion in its 3'-untranslated region. To assess the transmissibility of 2Adelta30 by mosquitoes, we compared its in vivo replication in mosquitoes with that of its wild type DEN-4 parent. Both the vaccine candidate and wild type virus were equally able to infect the mosquito Toxorhynchites splendens after intrathoracic inoculation. Relative to its wild type parent, 2Adelta30 was slightly restricted in its ability to infect the midgut of Aedes aegypti mosquitoes fed on an artificial blood meal and was even more restricted in its ability to disseminate from the midgut to the salivary glands. Thus, the 30-nucleotide deletion rendered the vaccine candidate more sensitive than its wild type parent to the mosquito midgut escape barrier. Most significantly, 2Adelta30 was not transmitted to 352 Ae. albopictus mosquitoes fed on 10 vaccinees, all of whom were infected with the vaccine candidate.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
J. H. McArthur, A. P. Durbin, J. A. Marron, K. A. Wanionek, B. Thumar, D. J. Pierro, A. C. Schmidt, J. E. Blaney Jr, B. R. Murphy, and S. S. Whitehead
Phase I Clinical Evaluation of rDEN4{Delta}30-200,201: A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity
Am J Trop Med Hyg, November 1, 2008; 79(5): 678 - 684.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
K. L. McELROY, K. A. TSETSARKIN, D. L. VANLANDINGHAM, and S. HIGGS
MANIPULATION OF THE YELLOW FEVER VIRUS NON-STRUCTURAL GENES 2A AND 4B AND THE 3'NON-CODING REGION TO EVALUATE GENETIC DETERMINANTS OF VIRAL DISSEMINATION FROM THE AEDES AEGYPTI MIDGUT
Am J Trop Med Hyg, December 1, 2006; 75(6): 1158 - 1164.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. HIGGS, D. L. VANLANDINGHAM, K. A. KLINGLER, K. L. MCELROY, C. E. MCGEE, L. HARRINGTON, J. LANG, T. P. MONATH, and F. GUIRAKHOO
GROWTH CHARACTERISTICS OF CHIMERIVAX-DEN VACCINE VIRUSES IN AEDES AEGYPTI AND AEDES ALBOPICTUS FROM THAILAND
Am J Trop Med Hyg, November 1, 2006; 75(5): 986 - 993.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Y.-H. Huang, S. J. Silengo, M. C. Whiteman, and R. M. Kinney
Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus
J. Virol., June 15, 2005; 79(12): 7300 - 7310.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. E. Bryant, P. F. C. Vasconcelos, R. C. A. Rijnbrand, J. P. Mutebi, S. Higgs, and A. D. T. Barrett
Size Heterogeneity in the 3' Noncoding Region of South American Isolates of Yellow Fever Virus
J. Virol., March 15, 2005; 79(6): 3807 - 3821.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. E. BLANEY JR., C. T. HANSON, C.-Y. FIRESTONE, K. A. HANLEY, B. R. MURPHY, and S. S. WHITEHEAD
GENETICALLY MODIFIED, LIVE ATTENUATED DENGUE VIRUS TYPE 3 VACCINE CANDIDATES
Am J Trop Med Hyg, December 1, 2004; 71(6): 811 - 821.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Y.-H. Huang, S. Butrapet, K. R. Tsuchiya, N. Bhamarapravati, D. J. Gubler, and R. M. Kinney
Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development
J. Virol., November 1, 2003; 77(21): 11436 - 11447.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Cologna and R. Rico-Hesse
American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells
J. Virol., April 1, 2003; 77(7): 3929 - 3938.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. S. Whitehead, B. Falgout, K. A. Hanley, J. E. Blaney Jr., L. Markoff, and B. R. Murphy
A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys
J. Virol., December 20, 2002; 77(2): 1653 - 1657.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
K. A. Hanley, J. J. Lee, J. E. Blaney Jr, B. R. Murphy, and S. S. Whitehead
Paired Charge-to-Alanine Mutagenesis of Dengue Virus Type 4 NS5 Generates Mutants with Temperature-Sensitive, Host Range, and Mouse Attenuation Phenotypes
J. Virol., January 15, 2002; 76(2): 525 - 531.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.